• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺非典型导管筛状增生具有与前列腺导管癌相似的分子和临床病理特征。

Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.

作者信息

Hickman Richard A, Yu Hui, Li Jianhong, Kong Max, Shah Rajal B, Zhou Ming, Melamed Jonathan, Deng Fang-Ming

机构信息

*Department of Pathology and Urology, New York University Langone Medical Center, New York, NY †Miraca Life Sciences, Dallas, TX.

出版信息

Am J Surg Pathol. 2017 Apr;41(4):550-556. doi: 10.1097/PAS.0000000000000794.

DOI:10.1097/PAS.0000000000000794
PMID:28009609
Abstract

Atypical intraductal cribriform proliferations of the prostate (AIP) are loose cribriform proliferations of luminal cells that exhibit greater architectural complexity and/or nuclear atypia than high-grade prostatic intraepithelial neoplasia (HGPIN), but lack the diagnostic criteria for intraductal carcinoma (IDC). The significance of AIP has not been formally established. We compared the clinical, morphologic, and immunohistochemical characteristics of AIP with classic IDC in 310 radical prostatectomy specimens that were received over an 18-month period. Of the 310 cases, 46 cases had AIP only (n=10), IDC only (n=6), or AIP coexisting with IDC (n=30). The ERG status of all 46 AIP/IDC cases was identical to the nearby acinar carcinoma, contrasted to just 3 cases of HGPIN (7%, P<0.01). The degree of uniform phosphatase and tensin homolog (PTEN) loss in 34 selected cases was identical in AIP and IDC (66.7%). No foci of HGPIN showed uniform PTEN loss; there was only 38% concordance of PTEN expression pattern between HGPIN and the nearby acinar carcinoma, unlike AIP and IDC (77% and 81%, respectively, P<0.01). AIP-associated and/or IDC-associated carcinoma (n=46) showed a higher stage and grade compared with acinar-only carcinoma (n=264, P<0.01). AIP-associated carcinoma had similar clinicopathologic features as IDC-associated carcinoma, including preoperative prostate-specific antigen, Gleason score, extraprostatic extension, seminal vesicle invasion, and lymph node metastasis (n=36, P>0.05). In conclusion, AIP shares similar ERG/PTEN immunoprofiles and exhibits similar clinical behavior as IDC, warranting immediate repeat biopsy when AIP is identified on biopsy, as is recommended in the most recent WHO Classification of Tumours of the Urinary System and Male Genital Organs, 2016.

摘要

前列腺非典型导管筛状增生(AIP)是一种管腔细胞的疏松筛状增生,与高级别前列腺上皮内瘤变(HGPIN)相比,其结构复杂性和/或核异型性更高,但缺乏导管癌(IDC)的诊断标准。AIP的意义尚未得到正式确立。我们在18个月内接收的310例根治性前列腺切除标本中,比较了AIP与经典IDC的临床、形态学和免疫组化特征。在这310例病例中,46例仅患有AIP(n = 10)、仅患有IDC(n = 6)或AIP与IDC共存(n = 30)。所有46例AIP/IDC病例的ERG状态与附近的腺泡癌相同,相比之下,仅有3例HGPIN(7%,P<0.01)如此。在34例选定病例中,AIP和IDC中磷酸酶和张力蛋白同源物(PTEN)一致缺失的程度相同(66.7%)。没有HGPIN灶显示PTEN一致缺失;HGPIN与附近腺泡癌之间PTEN表达模式的一致性仅为38%,与AIP和IDC不同(分别为77%和81%,P<0.01)。与仅腺泡癌(n = 264)相比,AIP相关和/或IDC相关癌(n = 46)的分期和分级更高(P<0.01)。AIP相关癌与IDC相关癌具有相似的临床病理特征,包括术前前列腺特异性抗原、Gleason评分、前列腺外侵犯、精囊侵犯和淋巴结转移(n = 36,P>0.05)。总之,AIP与IDC具有相似的ERG/PTEN免疫表型,并且表现出相似的临床行为,因此当活检发现AIP时,需要立即重复活检,正如2016年最新版《世界卫生组织泌尿系统和男性生殖器官肿瘤分类》中所推荐的那样。

相似文献

1
Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.前列腺非典型导管筛状增生具有与前列腺导管癌相似的分子和临床病理特征。
Am J Surg Pathol. 2017 Apr;41(4):550-556. doi: 10.1097/PAS.0000000000000794.
2
Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma.前列腺核心针活检中的非典型导管内增生和导管内癌:一项比较临床病理和分子研究,并提出扩大导管内癌的形态谱。
Histopathology. 2017 Nov;71(5):693-702. doi: 10.1111/his.13273. Epub 2017 Aug 8.
3
Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.前列腺导管内癌的异质性临床病理特征:“前体样”与“普通型”病变的比较
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26. eCollection 2014.
4
ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.ETS 基因异常在前列腺非典型筛状病变中的意义:有助于鉴别前列腺导管内癌和筛状高级别前列腺上皮内瘤。
Am J Surg Pathol. 2010 Apr;34(4):478-85. doi: 10.1097/PAS.0b013e3181d6827b.
5
Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.前列腺导管内增生性病变的临床病理分析:前列腺导管内癌、高级别前列腺上皮内瘤变和非典型筛状病变。
Hum Pathol. 2014 Aug;45(8):1572-81. doi: 10.1016/j.humpath.2014.03.011. Epub 2014 Apr 12.
6
Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes.在前列腺针吸活检中检测到的非典型管内增生是未取样的管内癌和其他不良病理特征的标志物:62 例前瞻性临床病理研究,重点是病理结果。
Histopathology. 2019 Sep;75(3):346-353. doi: 10.1111/his.13878. Epub 2019 Jul 2.
7
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.前列腺导管内癌:39名泌尿外科病理学家的观察者间再现性调查
Ann Diagn Pathol. 2014 Dec;18(6):333-42. doi: 10.1016/j.anndiagpath.2014.08.010. Epub 2014 Sep 3.
8
Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.分子证据表明,浸润性腺癌可通过逆行性腺管定植模仿前列腺上皮内瘤变(PIN)和导管内癌。
J Pathol. 2016 Jan;238(1):31-41. doi: 10.1002/path.4628. Epub 2015 Oct 14.
9
ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.在无浸润性前列腺腺癌的膀胱前列腺切除标本中出现的孤立性高级别前列腺上皮内瘤变的ERG和PTEN状态。
Hum Pathol. 2016 Sep;55:117-25. doi: 10.1016/j.humpath.2016.04.017. Epub 2016 May 14.
10
Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.前列腺非典型筛状病变:与前列腺癌的关系及其对前列腺活检诊断的影响。
Am J Surg Pathol. 2010 Apr;34(4):470-7. doi: 10.1097/PAS.0b013e3181cfc44b.

引用本文的文献

1
[Current grading of prostate cancer. German version].[前列腺癌的当前分级。德文版]
Pathologie (Heidelb). 2025 Jul 2. doi: 10.1007/s00292-025-01446-6.
2
Identification of intraductal-to-invasive spatial transitions in prostate cancer: proposal for a new unifying model on intraductal carcinogenesis.前列腺癌中导管内至浸润性空间转变的识别:关于导管内癌发生的新统一模型的提议
Histopathology. 2025 Jun;86(7):1091-1100. doi: 10.1111/his.15414. Epub 2025 Jan 30.
3
Assessing the predictive value of intraductal carcinoma of the prostate (IDC-P) in determining abiraterone efficacy for metastatic hormone-sensitive prostate cancer (mHSPC) patients.
评估前列腺导管内癌(IDC-P)在确定阿比特龙对转移性激素敏感性前列腺癌(mHSPC)患者疗效方面的预测价值。
Prostate. 2025 Feb;85(2):130-139. doi: 10.1002/pros.24809. Epub 2024 Oct 28.
4
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.前列腺癌的组织病理学评估和分级:当前的问题和关键方面。
Asian J Androl. 2024 Nov 1;26(6):575-581. doi: 10.4103/aja202440. Epub 2024 Sep 10.
5
Updates of Prostate Cancer from the 2022 World Health Organization Classification of the Urinary and Male Genital Tumors.《2022年世界卫生组织泌尿系统及男性生殖器官肿瘤分类》中前列腺癌的更新内容
J Clin Transl Pathol. 2023 Jan-Mar;3(1):26-34. doi: 10.14218/jctp.2022.00029. Epub 2023 Jan 17.
6
Intraductal Carcinoma of the Prostate versus Simulants: A Differential Diagnosis Growing in Clinical Impact.前列腺导管内癌与模拟物:临床影响日益增大的鉴别诊断
Cancers (Basel). 2024 Mar 8;16(6):1097. doi: 10.3390/cancers16061097.
7
Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.前列腺癌中非典型导管内增生的生物标志物表达模式不同。
Virchows Arch. 2024 Oct;485(4):723-728. doi: 10.1007/s00428-023-03643-1. Epub 2023 Sep 14.
8
Prostate Pathology: What is New in the 2022 WHO Classification of Urinary and Male Genital Tumors?前列腺病理学:2022 年世卫组织泌尿系统和男性生殖器官肿瘤分类有哪些新内容?
Pathologica. 2022 Feb;115(1):41-56. doi: 10.32074/1591-951X-822. Epub 2023 Jan 16.
9
Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.前列腺中的筛状病变:着重于鉴别诊断及临床意义
Cancers (Basel). 2022 Jun 21;14(13):3041. doi: 10.3390/cancers14133041.
10
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.《世界卫生组织肿瘤分类第五版:前列腺癌分类、诊断和预后的演进问题》
Histopathology. 2022 Oct;81(4):447-458. doi: 10.1111/his.14711. Epub 2022 Aug 2.